A major international phase III clinical trial, led by Queen Mary University of London, has found that ocrelizumab – a ...

A major international Phase III clinical trial, led by Queen Mary University of London, has found that ocrelizumab—a ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib, delayed ...

Neuropsychiatric care in MS has seen major progress over the last 40 years, though more remains to be done, an expert in the ...

Stock Gains After Enrollment Milestone Reached Shares of Quantum BioPharma (NASDAQ:QNTM) rose 10% in premarket trading on ...

Researchers from Kyushu University have identified a potential therapeutic target for the treatment of advanced multiple sclerosis (MS), a potentially disabling condition associated with the central ...

Differences in the complexity of the EEG signal (yellow and red colors) in a specific brain area between the group with advanced multiple sclerosis and the control group, and multifractal spectra ...

Summary: A collaborative neurobiology study uncovered a cellular mechanism tied to the severe, rapid progression of multiple sclerosis (MS). Published by a multidisciplinary team analyzing human ...

While recent therapies have the potential to stall or delay the progression of multiple sclerosis, a new study shows that young Black and Hispanic women fare worse than young white women. Minority ...

In a significant step towards strengthening disability-inclusive healthcare and social protection in India, Members of ...

Researchers say delayed diagnosis, lack of awareness, expensive treatment, and poor access to neurological care continue affecting thousands of patients across the world, including India. Experts say ...

Does MS cause pain? Should people with MS exercise? Many common beliefs about MS aren’t true, but here we separate fact from fiction.